Medical devices market seen reaching $1.48 trillion by 2035

Market Research Future projects the global medical devices market will rise from $774 billion in 2026 to $1.484 trillion by 2035, driven by AI-enabled diagnostics, broader remote monitoring reimbursement and aging populations. The outlook points to faster growth in monitoring, nanotechnology and ambulatory care as care shifts away from hospitals.

Why it matters: - The market’s projected rise to $1.484 trillion by 2035 signals sustained demand for devices tied to diagnosis, monitoring, surgery and home care. - Growth is being driven by structural healthcare needs, not discretionary spending, which makes the category less exposed to normal consumer demand swings. - AI-enabled diagnostics, reimbursement for remote monitoring and older populations are expanding addressable demand across hospitals, clinics and home settings.

What happened: - Market Research Future said the global medical devices market will grow from $774 billion in 2026 to $1.484 trillion by 2035. - The firm pegged 2025 market size at $720 billion. - The forecast implies a 7.5% compound annual growth rate from 2026 to 2035. - The release included sample and customization links: Request a free sample and ask for customization. - A detailed report is available here: Read detailed insights.

The details: - AI-embedded diagnostic clearances are a major growth driver, with U.S. FDA 510(k) clearances for machine-learning-enabled devices reaching 168 in 2024, up from 97 in 2021. - The release said De Novo AI submissions have cut time-to-market from 18 months to under 9 months. - CMS added seven remote therapeutic monitoring CPT codes in 2024, broadening coverage beyond chronic disease into post-surgical recovery and behavioral health. - The release said reimbursement averages $55 to $120 per patient per month, creating recurring revenue for connected-sensor makers. - The Acute Hospital Care at Home waiver, extended through 2025 in the U.S., has enrolled more than 300 hospitals and reportedly cut readmissions by 38% versus traditional inpatient care. - The WHO projects the global population age 65 and older will double from 761 million in 2021 to 1.6 billion by 2050. - Geriatric patients consume 3 to 4 times the per-capita device spend of younger cohorts. - Diagnostic devices held about 42% revenue share in 2025. - Monitoring devices are the fastest-growing device type at 7.8% CAGR. - Surgical devices generated $198 billion in 2025. - Conventional electro-mechanical and disposable platforms held about 60% revenue share in 2025. - Nanotechnology and smart materials are the fastest-growing technology platform at 8.7% CAGR. - Cardiology held about 24% revenue share in 2025. - Neurology is the fastest-growing therapeutic area at 8.2% CAGR. - Orthopedics generated $130 billion in 2025. - Ophthalmology held 7.4% market share in 2025. - General surgery is growing at 8.6% CAGR. - Hospitals remained the largest end-user segment with about 61% share in 2025. - Ambulatory surgical centers are the fastest-growing end-user segment at 8.6% CAGR. - Clinics and physician offices generated $115 billion in 2025. - Home care settings are growing at 8.0% CAGR. - North America held about 48% share in 2025, with the U.S. generating roughly 82% of regional revenue. - Europe was the second-largest region at about 25% share in 2025. - Asia-Pacific was the fastest-growing region at 8.1% CAGR. - The Middle East and Africa held about 8.8% share in 2025.

Between the lines: - The forecast describes a market shifting from hardware-heavy procurement toward software-layered care delivery. - AI and remote monitoring are creating new revenue pools, but they also raise the bar for regulatory validation, reimbursement access and cybersecurity. - The release said connected devices face cybersecurity vulnerability rates of 2% to 5% after 24 months of deployment, which could slow adoption in some markets. - Europe’s MDR re-certification costs, estimated at more than EUR 10 billion cumulatively, may pressure smaller manufacturers. - Asia-Pacific’s growth reflects rising insurance coverage, manufacturing capacity and government-backed health spending, while North America remains the revenue center because of reimbursement depth. - The market remains medium-concentrated, with the top five companies holding an estimated 35% to 40% combined share.

What's next: - By 2030, the release expects AI-embedded diagnostics and autonomous decision support to become central to device management. - Market Research Future said about 20% of new 510(k) clearances could be AI-enabled by 2030. - Competitive advantage is expected to favor companies with proprietary training data and regulatory-grade algorithm validation. - The company’s cited growth areas include cardiac rhythm management, surgical robotics, continuous glucose monitoring, patient monitoring and connected care.

The bottom line: - The medical devices market is entering a long expansion cycle powered by aging populations, digital monitoring and AI-assisted diagnosis, with the biggest gains likely to come from connected and data-driven devices.